Glycobiology  ||| S:0 E:13 ||| NNP
of  ||| S:13 E:16 ||| IN
the  ||| S:16 E:20 ||| DT
cell  ||| S:20 E:25 ||| NN
surface ||| S:25 E:32 ||| NN
:  ||| S:32 E:34 ||| :
Its  ||| S:34 E:38 ||| PRP$
debt  ||| S:38 E:43 ||| NN
to  ||| S:43 E:46 ||| TO
cell  ||| S:46 E:51 ||| NN
electrophoresis  ||| S:51 E:67 ||| NNS
1940-65  ||| S:67 E:75 ||| VBP
This  ||| S:75 E:80 ||| DT
Review  ||| S:80 E:87 ||| NNP
describes  ||| S:87 E:97 ||| VBZ
how  ||| S:97 E:101 ||| WRB
in  ||| S:101 E:104 ||| IN
the  ||| S:104 E:108 ||| DT
period  ||| S:108 E:115 ||| NN
1940-1959  ||| S:115 E:125 ||| CD
cell  ||| S:125 E:130 ||| NN
electrophoresis  ||| S:130 E:146 ||| NNS
( ||| S:146 E:147 ||| -LRB-
in  ||| S:147 E:150 ||| IN
the  ||| S:150 E:154 ||| DT
earlier  ||| S:154 E:162 ||| JJR
literature  ||| S:162 E:173 ||| NN
often  ||| S:173 E:179 ||| RB
referred  ||| S:179 E:188 ||| VBN
to  ||| S:188 E:191 ||| TO
as  ||| S:191 E:194 ||| RB
' ||| S:194 E:195 ||| POS
microelectrophoresis ||| S:195 E:215 ||| NN
' ||| S:215 E:216 ||| POS
)  ||| S:216 E:218 ||| -RRB-
was  ||| S:218 E:222 ||| VBD
used  ||| S:222 E:227 ||| VBN
to  ||| S:227 E:230 ||| TO
explore  ||| S:230 E:238 ||| VB
the  ||| S:238 E:242 ||| DT
surface  ||| S:242 E:250 ||| NN
chemistry  ||| S:250 E:260 ||| NN
of  ||| S:260 E:263 ||| IN
cells ||| S:263 E:268 ||| NNS
.  ||| S:268 E:270 ||| .
Using  ||| S:270 E:276 ||| VBG
the  ||| S:276 E:280 ||| DT
erythrocyte  ||| S:280 E:292 ||| NN
as  ||| S:292 E:295 ||| IN
a  ||| S:295 E:297 ||| DT
suitable  ||| S:297 E:306 ||| JJ
model  ||| S:306 E:312 ||| NN
for  ||| S:312 E:316 ||| IN
the  ||| S:316 E:320 ||| DT
study  ||| S:320 E:326 ||| NN
of  ||| S:326 E:329 ||| IN
biological  ||| S:329 E:340 ||| JJ
membranes ||| S:340 E:349 ||| NN
,  ||| S:349 E:351 ||| ,
the  ||| S:351 E:355 ||| DT
early  ||| S:355 E:361 ||| JJ
investigators  ||| S:361 E:375 ||| NNS
were  ||| S:375 E:380 ||| VBD
agreed  ||| S:380 E:387 ||| VBN
on  ||| S:387 E:390 ||| IN
the  ||| S:390 E:394 ||| DT
presence  ||| S:394 E:403 ||| NN
of  ||| S:403 E:406 ||| IN
negatively  ||| S:406 E:417 ||| RB
charged  ||| S:417 E:425 ||| VBN
groups  ||| S:425 E:432 ||| NNS
at  ||| S:432 E:435 ||| IN
the  ||| S:435 E:439 ||| DT
surface  ||| S:439 E:447 ||| NN
of  ||| S:447 E:450 ||| IN
this  ||| S:450 E:455 ||| DT
cell ||| S:455 E:459 ||| NN
.  ||| S:459 E:461 ||| .
The  ||| S:461 E:465 ||| DT
contemporary  ||| S:465 E:478 ||| JJ
dogma  ||| S:478 E:484 ||| NN
was  ||| S:484 E:488 ||| VBD
that  ||| S:488 E:493 ||| IN
these  ||| S:493 E:499 ||| DT
were  ||| S:499 E:504 ||| VBD
phosphate  ||| S:504 E:514 ||| JJ
groups  ||| S:514 E:521 ||| NNS
associated  ||| S:521 E:532 ||| VBN
with  ||| S:532 E:537 ||| IN
phospholipids ||| S:537 E:550 ||| NN
.  ||| S:550 E:552 ||| .
Work  ||| S:552 E:557 ||| NN
in  ||| S:557 E:560 ||| IN
the  ||| S:560 E:564 ||| DT
1960s ||| S:564 E:569 ||| NNS
,  ||| S:569 E:571 ||| ,
particularly  ||| S:571 E:584 ||| RB
on  ||| S:584 E:587 ||| IN
changes  ||| S:587 E:595 ||| NNS
in  ||| S:595 E:598 ||| IN
the  ||| S:598 E:602 ||| DT
electrokinetic  ||| S:602 E:617 ||| JJ
properties  ||| S:617 E:628 ||| NNS
of  ||| S:628 E:631 ||| IN
erythrocytes  ||| S:631 E:644 ||| JJ
following  ||| S:644 E:654 ||| JJ
treatment  ||| S:654 E:664 ||| NN
with  ||| S:664 E:669 ||| IN
proteolytic  ||| S:669 E:681 ||| JJ
enzymes ||| S:681 E:688 ||| NN
,  ||| S:688 E:690 ||| ,
lead  ||| S:690 E:695 ||| NN
to  ||| S:695 E:698 ||| TO
the  ||| S:698 E:702 ||| DT
realization  ||| S:702 E:714 ||| NN
that  ||| S:714 E:719 ||| IN
the  ||| S:719 E:723 ||| DT
negatively  ||| S:723 E:734 ||| RB
charged  ||| S:734 E:742 ||| VBN
groups  ||| S:742 E:749 ||| NNS
at  ||| S:749 E:752 ||| IN
the  ||| S:752 E:756 ||| DT
red  ||| S:756 E:760 ||| JJ
cell  ||| S:760 E:765 ||| NN
surface  ||| S:765 E:773 ||| NN
are  ||| S:773 E:777 ||| VBP
predominantly  ||| S:777 E:791 ||| RB
due  ||| S:791 E:795 ||| JJ
to  ||| S:795 E:798 ||| TO
sialic  ||| S:798 E:805 ||| VB
acids  ||| S:805 E:811 ||| VBN
carried  ||| S:811 E:819 ||| VBN
on  ||| S:819 E:822 ||| IN
glycoproteins ||| S:822 E:835 ||| NN
.  ||| S:835 E:837 ||| .
It  ||| S:837 E:840 ||| PRP
quickly  ||| S:840 E:848 ||| RB
became  ||| S:848 E:855 ||| VBD
apparent  ||| S:855 E:864 ||| JJ
from  ||| S:864 E:869 ||| IN
cell  ||| S:869 E:874 ||| NN
electrophoresis  ||| S:874 E:890 ||| NN
that  ||| S:890 E:895 ||| IN
sialic  ||| S:895 E:902 ||| JJ
acids  ||| S:902 E:908 ||| NNS
have  ||| S:908 E:913 ||| VBP
a  ||| S:913 E:915 ||| DT
ubiquitous  ||| S:915 E:926 ||| JJ
presence  ||| S:926 E:935 ||| NN
on  ||| S:935 E:938 ||| IN
the  ||| S:938 E:942 ||| DT
surface  ||| S:942 E:950 ||| NN
of  ||| S:950 E:953 ||| IN
animal  ||| S:953 E:960 ||| JJ
cells ||| S:960 E:965 ||| NNS
.  ||| S:965 E:967 ||| .
This  ||| S:967 E:972 ||| DT
finding  ||| S:972 E:980 ||| VBG
required  ||| S:980 E:989 ||| VBN
that  ||| S:989 E:994 ||| IN
any  ||| S:994 E:998 ||| DT
complete  ||| S:998 E:1007 ||| JJ
model  ||| S:1007 E:1013 ||| NN
of  ||| S:1013 E:1016 ||| IN
the  ||| S:1016 E:1020 ||| DT
plasma  ||| S:1020 E:1027 ||| JJ
membrane  ||| S:1027 E:1036 ||| NN
must  ||| S:1036 E:1041 ||| MD
include  ||| S:1041 E:1049 ||| VB
glycosylated  ||| S:1049 E:1062 ||| JJ
molecules  ||| S:1062 E:1072 ||| NNS
at  ||| S:1072 E:1075 ||| IN
the  ||| S:1075 E:1079 ||| DT
cell  ||| S:1079 E:1084 ||| NN
periphery ||| S:1084 E:1093 ||| NN
,  ||| S:1093 E:1095 ||| ,
thus  ||| S:1095 E:1100 ||| RB
laying  ||| S:1100 E:1107 ||| VBG
the  ||| S:1107 E:1111 ||| DT
foundations  ||| S:1111 E:1123 ||| NNS
for  ||| S:1123 E:1127 ||| IN
the  ||| S:1127 E:1131 ||| DT
field  ||| S:1131 E:1137 ||| NN
termed  ||| S:1137 E:1144 ||| NN
' ||| S:1144 E:1145 ||| POS
Glycobiology  ||| S:1145 E:1158 ||| NNP
of  ||| S:1158 E:1161 ||| IN
the  ||| S:1161 E:1165 ||| DT
Cell  ||| S:1165 E:1170 ||| NNP
Surface ||| S:1170 E:1177 ||| NNP
' ||| S:1177 E:1178 ||| POS
.  ||| S:1178 E:1180 ||| .
